Olivier BOHUON Appointed Chief Executive Officer of Pierre Fabre SA

CASTRES, France, September 1, 2010 - During its first meeting, the Board of Directors of Pierre
Fabre SA chaired by Mr. Pierre Fabre appointed Olivier BOHUON as the
company's Chief Executive Officer.

Olivier BOHUON, 51, has until now been the executive
vice-president of Abbott Corporation and president of its pharmaceutics
division. In this capacity, he directed the group's entire pharmaceutical
business (22 billion dollars turnover) from Chicago. He also became group
president for Europe in 2003 and subsequently president of Abbott
international.

Olivier BOHUON has also been appointed president of Pierre
Fabre Médicament as of today.

About the Pierre Fabre group

The Pierre Fabre group, owned on a majority basis by a public utility
Foundation, is France's second largest independent pharmaceutics laboratory
and the leader in cosmetics products sold in pharmacies.

It employs a workforce of nearly 10,000 including 1,400 in research.

In 2009, the Pierre Fabre group achieved a turnover of 1.8 billion EUR
and dedicated 28% of its medical turnover to research and development in
three main therapeutic areas: oncology, central nervous system, dermatology
and cardio-vascular/metabolism.

To find out more about Laboratoires Pierre Fabre :
www.pierre-fabre.com

Press contacts: Djamila Hazene-Kedjem: +33(0)1-49-10-81-12, +33(0)6-89-45-87-95,
djamila.hazene.kedjem at pierre-fabre.com